Midgard Science
P

ProtaGene

Dortmund, Germanyprotagene.comFrom their website, Nov 2026

  • GLP
  • GMP
  • CLIA

Work here? Claim this listing

About

ProtaGene is a contract research organization serving biopharmaceutical, cell therapy, and gene therapy developers. It provides analytical services for research through commercialization, with sites in Burlington, Massachusetts, and Dortmund, Heilbronn, and Heidelberg, Germany.

Services

  • Biotherapeutic Characterization Services

    Provides protein characterization method development and analytical characterization covering structural assessment, biological activity, and product and process impurities for biotherapeutics.

  • Cell-Based Assays

    Develops and runs cell-based assays to evaluate efficacy and safety, including molecule-specific assays tailored to client needs.

  • Manufacturing and QC

    Supports manufacturing and quality control activities, including release testing for biopharmaceutical products.

  • Clinical Sample In Vivo CQA Mapping

    Supports analytical work on clinical samples and in vivo critical quality attribute mapping.

  • Molecular Bioanalysis

    Provides biodistribution, transgene expression, and vector shedding analyses for gene therapy development and clinical safety evaluation.

  • Integration Site Analysis

    Analyzes vector integration sites for gene therapy programs using sensitive data analysis platforms.

  • Vector Characterization

    Supports characterization of viral vectors and related safety and impurity assessments.

  • Long-Read Sequencing Services

    Uses Oxford Nanopore sequencing to resolve complex genomic regions, structural variants, and transcript isoforms.

7 more services
  • Bioinformatics – NGS Data Analytics
  • Genome and Gene Editing
  • Gene Expression Quantitation
  • Commercial Patient Testing
  • Biologics Analytical Development
  • Biosimilar Testing
  • Cell & Gene Analytics

Capabilities

Assays and studies
  • Bioanalysis
  • Cell-based assays
  • In vivo
  • NGS
  • Analytical development
  • AAV
17 more
  • ADCs
  • Cell therapy
  • Forced degradation studies
  • Product-related isoform and impurity analysis
  • Comparability studies
  • Primary sequence analysis
  • PTM analysis
  • Disulfide linkage mapping
  • N-glycosylation analysis
  • Amino acid analysis
  • Extinction coefficient determination
  • Size exclusion chromatography
  • Biodistribution analysis
  • Transgene expression analysis
  • Vector shedding analysis
  • Integration site analysis
  • Vector production impurity profiling
Scale and capacity
Four sites in Europe and North America
Therapeutic areas
  • Biopharmaceuticals
  • Cell therapy
  • Gene therapy

Instruments and platforms

  • Oxford Nanopore sequencing technology
  • LC-MS
  • LC-MS/MS

Modalities and species

Modalities
  • Antibody
  • Bispecific
  • ADC
  • Viral vector
  • Cell therapy
  • Gene editing
  • Biosimilar
Species and models
  • Tissues
  • Blood
  • Biofluids

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    Scope: Dortmund and Heilbronn sites; GMP lot release testing of commercial protein products

  • GLPSelf-reported

    Scope: Heidelberg and Boston sites, as appropriate

  • CLIASelf-reported

Company

Type
CRO
Founded
2021

Locations

Office
60 Blanchard Road Burlington, MA 01803 USA
Sites
Burlington, Massachusetts, United States · Heilbronn, Germany · Heidelberg, Germany
Serves
Worldwide, Europe, North America, US, EMA

Contacts

Public records

CMS CLIA laboratory
99D2327251 source

Similar labs